Future perspectives for hepatocellular carcinoma
Author:
Abstract
Much of the progress in the developing field of hepatocellular carcinoma (HCC) depends on general progress in oncology, on many non‐cancer‐related areas such as antiviral therapeutics and treatment of chronic liver disease, and on public health initiatives. It would therefore be inappropriate to make predictions in this field for the very near future, i.e. the next 1–2 years, and it would be difficult for the distant future of 100 years and beyond. The aim of this article is to survey the current status of the field and, on the basis of current knowledge, to make predictions for the next decade. Five facets of HCC are identified that impact on future directions in the management of the disease: epidemiology, prevention, screening, diagnosis and therapy.Keywords
This publication has 35 references indexed in Scilit:
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Percutaneous Local Ablative Therapy for Hepatocellular CarcinomaAnnals of Surgery, 2003
- Management of Chronic Hepatitis B: An OverviewSeminars in Liver Disease, 2002
- Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinomaHepatology, 2002
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Surveillance for hepatocellular carcinoma in cirrhosis: is it cost-effective?European Journal Of Cancer Prevention, 2001
- Review article: overview of medical treatments in unresectable hepatocellular carcinoma—an impossible meta‐analysis?Alimentary Pharmacology & Therapeutics, 1998
- Improved survival with percutaneous ethanol injection in patients with large hepatocellular carcinomaEuropean Journal of Gastroenterology & Hepatology, 1994
- Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma.Gut, 1993
- A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinomaJournal of Hepatology, 1990